Ling Wei
Impact in
- Hepatology top 10%
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
- Autophagy in Disease and Therapy
- Hepatitis B Virus Studies
Papers in
- Epidemiology 18
- Nail Diseases and Treatments 5
- Liver Disease Diagnosis and Treatment 5
- Hepatitis B Virus Studies 3
- Fungal Infections and Studies 3
- Autophagy in Disease and Therapy 3
- Co-authors
- Cory J. Xian (1 shared paper)Xing Lin (5 shared papers)Lang Zhuo (5 shared papers)Renbin Huang (4 shared papers)Shijun Zhang (3 shared papers)Alexis Kaushansky (12 shared papers)David K. C. Cooper (4 shared papers)Hanchao Gao (4 shared papers)
- Journals
- Mycoses (4 papers)Xenotransplantation (3 papers)Cell chemical biology (2 papers)Vaccine (2 papers)Frontiers in Cellular and Infection Microbiology (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Ling Wei
57 papers receiving 885 citations
Peers
Comparison fields: 5 of 119
- Hepatology 70
- Epidemiology 207
- Infectious Diseases 96
- Pharmacology 42
- Cardiology and Cardiovascular Medicine 78
Countries citing papers authored by Ling Wei
This map shows the geographic impact of Ling Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Wei more than expected).
Fields of papers citing papers by Ling Wei
This network shows the impact of papers produced by Ling Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Wei. The network helps show where Ling Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 96 | |
| 2 | 2020 | 66 | |
| 3 | 2017 | 59 | |
| 4 | 2012 | 57 | |
| 5 | 2013 | 51 | |
| 6 | 2013 | 42 | |
| 7 | 2013 | 40 | |
| 8 | 2023 | 39 | |
| 9 | 2018 | 35 | |
| 10 | 2017 | 35 | |
| 11 | 2021 | 32 | |
| 12 | 2013 | 28 | |
| 13 | 2020 | 26 | |
| 14 | Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor. | 2012 | 21 |
| 15 | 2021 | 19 | |
| 16 | 2024 | 19 | |
| 17 | 2012 | 18 | |
| 18 | 2019 | 17 | |
| 19 | 2023 | 15 | |
| 20 | 2022 | 12 |
About Ling Wei
Ling Wei is a scholar working on Epidemiology, Molecular Biology, Public Health, Environmental and Occupational Health, Surgery and Oncology, having authored 62 papers that have together received 901 indexed citations. Recurring topics across this work include Nail Diseases and Treatments (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Malaria Research and Control (5 papers), Hepatitis B Virus Studies (3 papers), Fungal Infections and Studies (3 papers), Xenotransplantation and immune response (3 papers), Autophagy in Disease and Therapy (3 papers) and Postharvest Quality and Shelf Life Management (3 papers). The work is most often cited by research in Hepatology (70 citations), Epidemiology (207 citations), Infectious Diseases (96 citations), Pharmacology (42 citations) and Cardiology and Cardiovascular Medicine (78 citations). Ling Wei has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Cory J. Xian, Xing Lin, Lang Zhuo, Renbin Huang, Shijun Zhang, Alexis Kaushansky, David K. C. Cooper, Hanchao Gao, Quanfang Huang and Yanli Zhao. Their work appears in journals such as Mycoses, Xenotransplantation, Cell chemical biology, Vaccine and Frontiers in Cellular and Infection Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.